FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to novel compounds of the formula (I): , wherein X represents heteroatom, such as oxygen (O) or sulfur (S) atoms; X and Z mean independently of one another one or some identical or different substitutes bound any available carbon atom and they can represent hydrogen atom or halogen atom; R1 represents a substitute of the formula (II): , wherein R2 and R3 can represent simultaneously or independently of one another hydrogen atom or (C1-C4)-alkyl, or R1 can represent hydrogen, halogen atom, (C1-C7)-alkyl, -CHO, -(CH2)2COOH, -(CH2)2CO2Et, (CH2)mL wherein L means -OH or bromine atom (Br); m represents a whole number from 1 to 3; n represents a whole number from 0 to 3; Q1 and Q2 represent independently of one another oxygen atom or group of the formula: wherein substitutes y1 and y2 represent hydrogen atom, and to their pharmacologically acceptable salts. Also, invention relates to use of these compounds as intermediate substances used in synthesis of novel compounds of dibenzoazulene class, and to their using for preparing drugs.
EFFECT: valuable medicinal properties of compounds.
9 cl, 4 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF BENZONAPHTHOAZULENE, THEIR USING AS INTERMEDIATE SUBSTANCES AND FOR PREPARING PHARMACEUTICAL COMPOSITIONS DESIGNATED FOR INHIBITION OF PRODUCING TNF-α | 2003 |
|
RU2318827C2 |
2-THIADIBENZOAZULENES AS INHIBITORS OF TUMOUR NECROSIS FACTOR PRODUCING AND INTERMEDIATE PRODUCTS FOR PRODUCTION THEREOF | 2003 |
|
RU2334749C2 |
NEW ALKYLATING AGENTS | 2013 |
|
RU2632206C2 |
CONDENSED TRICYCLIC COMPOUNDS AS INHIBITORS OF TUMOUR NECROSIS FACTOR-ALFA | 2005 |
|
RU2406724C2 |
APPLICATION OF OXOZALIDINON-CHYNOLYN HYBRID ANTIBIOTICS FOR TREATMENT OF ANTHRAX AND OTHER INFECTIONS | 2004 |
|
RU2351335C2 |
DERIVATIVES OF BENZODIAZEPINE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2278865C2 |
FUNCTIONALIZED DERIVATIVES OF TIEINODOLA FOR TREATMENT OF CANCER DISEASE | 2013 |
|
RU2632199C2 |
ANELLATED CABAMOYLAZAHETEROCYCLES, FOCUSED LIBRARY, PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2005 |
|
RU2281947C1 |
DERIVATIVES OF 3-(5-CHLORO-2-OXOBENZO[D]OXAZOL-3(2H)-YL)PROPANOIC ACID AS KMO INHIBITORS | 2014 |
|
RU2693016C1 |
OXADIAZOLONE DERIVATIVES AS PPAR-DELTA AGONISTS | 2005 |
|
RU2374243C2 |
Authors
Dates
2008-04-27—Published
2003-04-09—Filed